The National Graduate School in Infection Biology and Antimicrobials (or IBA) is a research school (forskerskole) funded by the Research Council of Norway, coordinated at the University of Oslo. Both PhD students and postdocs registered at Norwegian universities are welcome to apply for membership in IBA. Our program funds courses and workshops and research stays abroad/in Norway, has annual networking meetings, and we support participation in these activities by co-funding of travel and accommodation costs.
Latest news:2020-07-03 10:18:43
17th of June 2020 the local IBA committee in Trondheim arranged a meeting informing about the IBA National Graduate School and its upcoming activities, and held a session on how to turn PhD degrees into meaningful careers. For the latter, Dr. Christopher Cornthwaite gave an inspiring online talk on the importance of owning your own career path and how to get the most out of your degree.
Chris is a PhD in religious studies and founder of the career-building Roostervane community for advanced-degree holders.
20 people participated and pizza was served!
Upcoming courses and events for IBA members
IBA annual meeting – October 26-27 – Trondheim. Open to all members. Read more and register here.
Nature Masterclass – Scientific Writing course. November 5-6th – Oslo. This course is organised in collaboration with the journal Nature! Learn how to get the most out of the writing process and how to get published in top-ranked journals. Read more here.
IBA course – Mol8009 – Molecular Mechanisms of Inflammation – NTNU – November 9-13. The course will give an overview of mechanisms and signaling pathways involved in inflammatory processes related to infections, but also sterile inflammation. Read more here.
Effective Collaboration in Research – Nature Masterclass. The course is online and you can start at any time you´d like. More information.
Start planning your application for travel grants for research stays in Norway and abroad. This is an offer for PhD-student members (and medical research students). You can apply from September 15th. Find out what you need for your application here.
Application for financial support for external courses will be reopened October 15th. Read more and find courses here.
Future activities under development
Antibiotics and Antibiotic Resistance Course 2021. The course was planned for autumn 2020, but is now being postponed until spring/early summer 2021. The coursed was offered in 2018. Take a look at the program here.
Not an IBA member? Apply for membership here.
Do you want to learn how and when to plan a grant application?
Read more here
We have invited Jørgen Kirksæther to talk about how to begin and how to improve existing applications.
All members are welcome.
Jørgen Kirksæther works as a senior adviser in the Section for Research at the Faculty of Mathematics and Natural Sciences at UiO. His fields of expertise is project administration and development, as well as application guidance.
IBA offers a course on Scientific Writing from April 20-24th. The course is meant to provide a virtual space to meet up, learn and talk about your writing during these unconventional times.
Instructor: Mathew Stiller-Reeve.
Free online MIT seminar entitled “Dealing with Coronavirus: An Industry Perspective”. Wed, April 1, 2020, 10:30 PM – 12:00 PM CET.
Given by Stéphane Bancel, CEO of Moderna. Hosted by the MIT Sloan School of Management (Boston).
Link for info and registration: https://mitsloan.mit.edu/events/2020-04-01-dealing-coronavirus-industry-perspective
Background: After just 42 days, Moderna produced a batch of vaccines ready for clinical trials- from sequence identification through vaccine design, manufacturing, and shipment.
Co-hosted by MIT’s Laboratory for Financial Engineering and Golub Center for Finance and Policy, join a conversation with Stéphane Bancel, CEO of Moderna, as he describes the science, business, and policy issues surrounding the first and currently only company with a vaccine for coronavirus in clinical trials at the National Institute of Health (NIH).
The project is also funded by The Coalition for Epidemic Preparedness Innovations (CEPI), headquartered in Oslo.